Annual CFI
-$5.50 M
-$1.00 M-22.22%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual cash flow from investing activities is -$5.50 million, with the most recent change of -$1.00 million (-22.22%) on December 31, 2023.
- SLS annual CFI is now -145.24% below its all-time high of $12.16 million, reached on December 31, 2017.
Performance
SLS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, SLS quarterly CFI has stayed the same.
- SLS quarterly CFI is now -100.00% below its all-time high of $12.16 million, reached on December 31, 2017.
Performance
SLS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$0.00
+$3.00 M+100.00%
September 30, 2024
Summary
- As of February 8, 2025, SLS TTM cash flow from investing activities is $0.00, with the most recent change of +$3.00 million (+100.00%) on September 30, 2024.
- Over the past year, SLS TTM CFI has increased by +$5.50 million (+100.00%).
- SLS TTM CFI is now -100.00% below its all-time high of $12.16 million, reached on December 31, 2017.
Performance
SLS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SLS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.2% | 0.0% | +100.0% |
| 3 y3 years | - | +100.0% | +100.0% |
| 5 y5 years | - | +100.0% | +100.0% |
SLS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | at high | +100.0% | at high | +100.0% |
| 5 y | 5-year | <-9999.0% | at low | at high | +100.0% | at high | +100.0% |
| alltime | all time | -145.2% | +54.3% | -100.0% | +100.0% | -100.0% | +100.0% |
SELLAS Life Sciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2024 | - | $0.00(0.0%) | -$3.00 M(-45.5%) |
| Dec 2023 | -$5.50 M(+22.2%) | $0.00(-100.0%) | -$5.50 M(0.0%) |
| Sep 2023 | - | -$3.00 M(+20.0%) | -$5.50 M(+120.0%) |
| Jun 2023 | - | -$2.50 M(<-9900.0%) | -$2.50 M(-44.4%) |
| Dec 2022 | -$4.50 M(<-9900.0%) | $0.00(0.0%) | -$4.50 M(0.0%) |
| Sep 2022 | - | $0.00(-100.0%) | -$4.50 M(0.0%) |
| Jun 2022 | - | -$4.50 M(<-9900.0%) | -$4.50 M(<-9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2017 | $12.16 M(<-9900.0%) | $12.16 M(>+9900.0%) | $12.16 M(+1152.1%) |
| Sep 2017 | - | $0.00(-100.0%) | $971.00 K(-1242.4%) |
| Dec 2016 | -$85.00 K(-100.8%) | $971.00 K(>+9900.0%) | -$85.00 K(-100.8%) |
| Sep 2016 | - | $0.00(0.0%) | $10.15 M(+2.5%) |
| Jun 2016 | - | $0.00(-100.0%) | $9.91 M(+0.5%) |
| Mar 2016 | - | -$1.06 M(-109.4%) | $9.86 M(-5.2%) |
| Dec 2015 | $10.39 M(-288.0%) | $11.21 M(-4620.6%) | $10.39 M(-1223.8%) |
| Sep 2015 | - | -$248.00 K(+396.0%) | -$925.00 K(-75.3%) |
| Jun 2015 | - | -$50.00 K(-90.3%) | -$3.75 M(-6.5%) |
| Mar 2015 | - | -$518.00 K(+375.2%) | -$4.01 M(-27.4%) |
| Dec 2014 | -$5.53 M(-54.1%) | -$109.00 K(-96.5%) | -$5.53 M(-32.8%) |
| Sep 2014 | - | -$3.08 M(+885.6%) | -$8.22 M(+85.7%) |
| Jun 2014 | - | -$312.00 K(-84.6%) | -$4.43 M(+11.1%) |
| Mar 2014 | - | -$2.03 M(-27.5%) | -$3.98 M(-66.9%) |
| Dec 2013 | -$12.04 M | -$2.80 M(-489.4%) | -$12.04 M(+30.4%) |
| Sep 2013 | - | $720.00 K(+449.6%) | -$9.24 M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $131.00 K(-101.3%) | -$9.96 M(-2.1%) |
| Mar 2013 | - | -$10.09 M(<-9900.0%) | -$10.17 M(>+9900.0%) |
| Dec 2012 | -$87.00 K(-721.4%) | $0.00(0.0%) | -$87.00 K(-53.7%) |
| Sep 2012 | - | $0.00(-100.0%) | -$188.00 K(0.0%) |
| Jun 2012 | - | -$87.00 K(<-9900.0%) | -$188.00 K(-448.1%) |
| Mar 2012 | - | $0.00(-100.0%) | $54.00 K(+285.7%) |
| Dec 2011 | $14.00 K(-113.2%) | -$101.00 K(<-9900.0%) | $14.00 K(-99.8%) |
| Sep 2011 | - | $0.00(-100.0%) | $6.06 M(+0.1%) |
| Jun 2011 | - | $155.00 K(-487.5%) | $6.06 M(-4690.2%) |
| Mar 2011 | - | -$40.00 K(-100.7%) | -$132.00 K(+24.5%) |
| Dec 2010 | -$106.00 K(+27.7%) | $5.95 M(<-9900.0%) | -$106.00 K(-98.2%) |
| Sep 2010 | - | -$5000.00(-99.9%) | -$6.05 M(-0.5%) |
| Jun 2010 | - | -$6.04 M(>+9900.0%) | -$6.09 M(+6738.2%) |
| Mar 2010 | - | -$14.00 K(<-9900.0%) | -$89.00 K(+7.2%) |
| Dec 2009 | -$83.00 K(-100.9%) | $0.00(-100.0%) | -$83.00 K(-100.9%) |
| Sep 2009 | - | -$36.00 K(-7.7%) | $8.82 M(+50.0%) |
| Jun 2009 | - | -$39.00 K(+387.5%) | $5.88 M(-3560.0%) |
| Mar 2009 | - | -$8000.00(-100.1%) | -$170.00 K(-101.8%) |
| Dec 2008 | $9.60 M(-195.8%) | $8.91 M(-399.2%) | $9.60 M(+284.2%) |
| Sep 2008 | - | -$2.98 M(-51.1%) | $2.50 M(-139.4%) |
| Jun 2008 | - | -$6.09 M(-162.4%) | -$6.33 M(+2317.9%) |
| Mar 2008 | - | $9.76 M(+440.8%) | -$262.00 K(-97.4%) |
| Dec 2007 | -$10.03 M(<-9900.0%) | $1.80 M(-115.3%) | -$10.03 M(-15.3%) |
| Sep 2007 | - | -$11.81 M(>+9900.0%) | -$11.83 M(>+9900.0%) |
| Jun 2007 | - | -$18.00 K(+1700.0%) | -$19.00 K(+1800.0%) |
| Mar 2007 | - | -$1000.00 | -$1000.00 |
| Dec 2006 | $0.00 | - | - |
FAQ
- What is SELLAS Life Sciences annual cash flow from investing activities?
- What is the all time high annual CFI for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual CFI year-on-year change?
- What is SELLAS Life Sciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly CFI year-on-year change?
- What is SELLAS Life Sciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for SELLAS Life Sciences?
- What is SELLAS Life Sciences TTM CFI year-on-year change?
What is SELLAS Life Sciences annual cash flow from investing activities?
The current annual CFI of SLS is -$5.50 M
What is the all time high annual CFI for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual cash flow from investing activities is $12.16 M
What is SELLAS Life Sciences annual CFI year-on-year change?
Over the past year, SLS annual cash flow from investing activities has changed by -$1.00 M (-22.22%)
What is SELLAS Life Sciences quarterly cash flow from investing activities?
The current quarterly CFI of SLS is $0.00
What is the all time high quarterly CFI for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly cash flow from investing activities is $12.16 M
What is SELLAS Life Sciences quarterly CFI year-on-year change?
Over the past year, SLS quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is SELLAS Life Sciences TTM cash flow from investing activities?
The current TTM CFI of SLS is $0.00
What is the all time high TTM CFI for SELLAS Life Sciences?
SELLAS Life Sciences all-time high TTM cash flow from investing activities is $12.16 M
What is SELLAS Life Sciences TTM CFI year-on-year change?
Over the past year, SLS TTM cash flow from investing activities has changed by +$5.50 M (+100.00%)